5 strategies for biotech startups to outlast a market downturn
To ensure survival, it’s essential to explore alternative funding methods rather than relying solely on classic fundraising.
5 investors explain why longevity tech is a long-term play
It’s becoming clear that longevity as a theme has resonated with investors, though it appears it will be some time before more generalist investors take interest.
Your future shrimp meal could come from Atarraya’s farming technology
The company's three-pronged technology includes creating ideal environment for the shrimp, remote operations management and AI-powered automation to monitor and feed them.
It’s the era of at-home health diagnostics and Senzo is finding its flow
Biotech company Senzo just raised a $2 million round at a $20 million pre-money valuation to further extend options for lateral flow diagnostics. “Lateral flow,” in this case, is the same
Hong Kong’s AI drug discovery firm Insilico closes $60M Series D
Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. It’s a sign that certain invest
Planetary wants to help food startups brew up more fake meat
Planetary aims to bring all of the alternative protein production planets into orbit with its scaling technology.
How compassion and inclusivity are helping Kindbody change the fertility industry
When the topic of fertility comes up, we often hear hushed tones discussing someone else’s or their own journey through infertility.
6 questions investors should ask when evaluating psychedelic biotech companies
We believe in a future where psychedelic therapy will be as common as going to the dentist, but the path won’t be easy.
NovaXS Biotech wants to make injection therapy needle-free
A startup spawned from a lab at the University of California, Berkeley has won investor support to work on its patented needle-free injector, which it hopes can make therapies that traditionally requi
COVID rapid tests available on e-commerce in China for the first time
China is allowing the public to take COVID-19 rapid antigen self-tests for the first time as infection numbers hit a two-year high in recent days. Online marketplaces including JD.com and Meituan are
Startup Battlefield winner Cellino grabs $80M Series A
Cellino Bio’s founder Nabiha Saklayen didn’t initially intend to enter TechCrunch Disrupt 2021’s Startup Battlefield — it was her PR advisor who threw the startup’s name in the ring as a
MycoWorks, making leather from fungi, closes $125M to scale production
The company touts its Fine Mycelium process as the only mycelium engineered to be made-to-order and made-to-specification.
Phytoform plants $5.7M into climate-resistant crop technology
The success of CRISPR technology in agriculture has been well documented as a way to manipulate plant genomes to make them more pest and climate resistant and grow more consistent products.
Longevica takes in $2.5M as it launches open research resources to examine life extension
Longevica's goal is to validate the pipeline of turning scientific research into consumer-ready products.
Tiamat Sciences cooking up plant-based proteins for cheaper production of cellular meat
Adil estimates that today’s growth factor costs $2 million per gram to make, but she believes that with efforts from Tiamat Sciences and others, that cost could come down 10 times.
Generate Biomedicines raises $370M Series B with a focus on protein-based drugs
The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round. Generate Biomedicines
Kiwi Bio aims to free irritable bowel syndrome sufferers from restrictive diets
The company has been busy strengthening its supply chain to gear up for scaling its product. Additionally, it hired a head of growth and a community engagement and success manager.
Cellino is using AI and machine learning to scale production of stem cell therapies
Cellino, a company developing a platform to automate stem cell production, presented today at TechCrunch Disrupt 2021’s Startup Battlefield to detail how its system, which combines AI technology
The next healthcare revolution will have AI at its center
Human life expectancy increased from 31 years in 1900 to 72 years in 2017. Today, we are on the cusp of another healthcare revolution driven by artificial intelligence.
Stockeld Dreamery loves cheese so much that it raised $20M to make it out of legumes
Stockeld Chunk is made using fermented legumes, which gives the cheese a feta-like look and feel and contains 13% protein.